Cargando…
First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension
Riociguat has been approved for use in adults with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. No clinical data on its therapeutic use in children with PAH are currently available. We report the case of a now four-year-old boy who initially presented at th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731721/ https://www.ncbi.nlm.nih.gov/pubmed/29099661 http://dx.doi.org/10.1177/2045893217743123 |